Loading
Quibim
Quibim (Quantitative Imaging Biomarkers in Medicine) is a Spanish biotechnology company headquartered in Valencia, Spain. The company formally began its commercial operations in 2020 and has emerged as a leader in the development of advanced imaging biomarkers and artificial intelligence (AI) solutions for the life sciences. Quibim has offices in Madrid, Barcelona, New York (USA), and Cambridge (UK), and maintains wholly owned subsidiaries in the USA and the UK.
Funding
Every round, secondary, debt facility or acquisition involving Quibim that Lounge tracks, newest first.
No rounds recorded yet.
Paid members see the full deals desk — every AI round and exit, filterable by type, sector and country, with investors and reported ARR, plus CSV exports. Developer membership is $9/mo.
See plans →Log inKey numbers
—
0
—
—